A new corporate tax break promises to let US drug makers to pocket an extra $75 billion in profits from sales overseas.
These big companies have been opposed to Americans re-importing prescription drugs. They claim that they lose money on drugs shipped overseas. But it seems they've been singing a different tune to the IRS. They've been telling the taxman for years that their profits come from international sales. (NYT)
No surprise here. At least, there shouldn't be. Thanks for the continued work of highlighting the waste and fraud that abounds.
ReplyDelete